This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Bremelanotide resulted in a significant change in validated questionnaires, but the clinical benefit is modest.
Why it matters
Understanding the efficacy and safety of bremelanotide can help address sexual dysfunction in women, a significant but often overlooked issue.
How the study worked
The study involved a literature search of peer-reviewed publications on bremelanotide's pharmacotherapy.
What this study cannot tell us
The study acknowledges the challenges of conducting clinical trials in this area, including high placebo effects and biases in outcome measures.
Read the original research
An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder.
Expert opinion on pharmacotherapy, 24(1), 15-21
Citation
Cipriani, Sarah; Alfaroli, Chiara; Maseroli, Elisa; Vignozzi, Linda. (2023). An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder.. Expert opinion on pharmacotherapy, 24(1), 15-21. https://doi.org/10.1080/14656566.2022.2132144